サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434786

抗菌成分市場：タイプ別、エンドユーザー別-2024-2030年の世界予測

Antimicrobial Ingredients Market by Type (Inorganic, Organic), End-User (Automotive & Transportation, Building & Construction, Food & Beverage) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
抗菌成分市場：タイプ別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

抗菌成分市場規模は2023年に44億2,000万米ドルと推計され、2024年には47億米ドルに達し、CAGR 6.79%で2030年には70億米ドルに達すると予測されます。

抗菌成分の世界市場

主な市場の統計
基準年[2023］ 44億2,000万米ドル
予測年[2024］ 47億米ドル
予測年［2030] 70億米ドル
CAGR（%） 6.79%
抗菌成分 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは抗菌成分市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、抗菌成分市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客ベース、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-抗菌成分市場の市場規模および予測は？

2-抗菌成分市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-抗菌成分市場における技術動向と規制の枠組みは？

4-抗菌成分市場における主要ベンダーの市場シェアは？

5-抗菌成分市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 健康と衛生問題に対する意識の向上
      • 消毒剤および表面消毒剤の需要の増大
      • 可処分所得の増加と抗菌化粧品の普及の増加
    • 抑制要因
      • 抗菌成分の原材料と配合に関連するコストの上昇
    • 機会
      • 植物ベースの抗菌製品への傾向
      • 新しく開発された抗菌成分のリリース
    • 課題
      • 抗菌成分の厳格な承認プロセス
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 抗菌成分市場：タイプ別

  • 無機
  • オーガニック

第7章 抗菌成分市場：エンドユーザー別

  • 自動車と輸送
  • 建築と建設
  • 飲食品
  • ヘルスケア
  • 繊維

第8章 南北アメリカの抗菌成分市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の抗菌成分市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの抗菌成分市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Ashland Global Holdings Inc
    • Avient Corporation
    • BASF SE
    • BioCote Limited
    • Clariant AG
    • Croda International PLC
    • Destiny Pharma PLC
    • DuPont de Nemours, Inc.
    • HeiQ PLC
    • Kemin Industries, Inc.
    • Lonza Group AG
    • LyondellBasell Industries Holdings B.V.
    • Merck KGaA
    • Microban International, Ltd.
    • Milliken & Company
    • Momentive Performance Materials Inc
    • NATUREX SA
    • Nouryon Chemicals Holding B.V.
    • Pfizer Inc.
    • RTP Company
    • Sanitized AG
    • Solvay SA
    • Stepan Company
    • Symrise AG
    • Wacker Chemie AG
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANTIMICROBIAL INGREDIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIMICROBIAL INGREDIENTS MARKET DYNAMICS
  • FIGURE 7. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AUTOMOTIVE & TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BUILDING & CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEXTILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 101. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. ANTIMICROBIAL INGREDIENTS MARKET LICENSE & PRICING
目次
Product Code: MRR-69324464D0D1

[193 Pages Report] The Antimicrobial Ingredients Market size was estimated at USD 4.42 billion in 2023 and expected to reach USD 4.70 billion in 2024, at a CAGR 6.79% to reach USD 7.00 billion by 2030.

Global Antimicrobial Ingredients Market

KEY MARKET STATISTICS
Base Year [2023] USD 4.42 billion
Estimated Year [2024] USD 4.70 billion
Forecast Year [2030] USD 7.00 billion
CAGR (%) 6.79%
Antimicrobial Ingredients Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antimicrobial Ingredients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antimicrobial Ingredients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Ingredients Market, highlighting leading vendors and their innovative profiles. These include Ashland Global Holdings Inc, Avient Corporation, BASF SE, BioCote Limited, Clariant AG, Croda International PLC, Destiny Pharma PLC, DuPont de Nemours, Inc., HeiQ PLC, Kemin Industries, Inc., Lonza Group AG, LyondellBasell Industries Holdings B.V., Merck KGaA, Microban International, Ltd., Milliken & Company, Momentive Performance Materials Inc, NATUREX SA, Nouryon Chemicals Holding B.V., Pfizer Inc., RTP Company, Sanitized AG, Solvay SA, Stepan Company, Symrise AG, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Inorganic
    • Organic
  • End-User
    • Automotive & Transportation
    • Building & Construction
    • Food & Beverage
    • Healthcare
    • Textile
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antimicrobial Ingredients Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antimicrobial Ingredients Market?

3. What are the technology trends and regulatory frameworks in the Antimicrobial Ingredients Market?

4. What is the market share of the leading vendors in the Antimicrobial Ingredients Market?

5. Which modes and strategic moves are suitable for entering the Antimicrobial Ingredients Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antimicrobial Ingredients Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness regarding health and hygiene issues
      • 5.1.1.2. Growing demand for sanitizers and surface disinfectants
      • 5.1.1.3. Rise in disposable income and higher adoption of antimicrobial cosmetic products
    • 5.1.2. Restraints
      • 5.1.2.1. Rising costs associated with raw materials and formulation of antimicrobial ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclination toward plant-based antimicrobial products
      • 5.1.3.2. Launch of newly developed antimicrobial ingredients
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval processes of antimicrobial ingredients
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Antimicrobial Ingredients Market, by Type

  • 6.1. Introduction
  • 6.2. Inorganic
  • 6.3. Organic

7. Antimicrobial Ingredients Market, by End-User

  • 7.1. Introduction
  • 7.2. Automotive & Transportation
  • 7.3. Building & Construction
  • 7.4. Food & Beverage
  • 7.5. Healthcare
  • 7.6. Textile

8. Americas Antimicrobial Ingredients Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antimicrobial Ingredients Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antimicrobial Ingredients Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Ashland Global Holdings Inc
    • 12.1.2. Avient Corporation
    • 12.1.3. BASF SE
    • 12.1.4. BioCote Limited
    • 12.1.5. Clariant AG
    • 12.1.6. Croda International PLC
    • 12.1.7. Destiny Pharma PLC
    • 12.1.8. DuPont de Nemours, Inc.
    • 12.1.9. HeiQ PLC
    • 12.1.10. Kemin Industries, Inc.
    • 12.1.11. Lonza Group AG
    • 12.1.12. LyondellBasell Industries Holdings B.V.
    • 12.1.13. Merck KGaA
    • 12.1.14. Microban International, Ltd.
    • 12.1.15. Milliken & Company
    • 12.1.16. Momentive Performance Materials Inc
    • 12.1.17. NATUREX SA
    • 12.1.18. Nouryon Chemicals Holding B.V.
    • 12.1.19. Pfizer Inc.
    • 12.1.20. RTP Company
    • 12.1.21. Sanitized AG
    • 12.1.22. Solvay SA
    • 12.1.23. Stepan Company
    • 12.1.24. Symrise AG
    • 12.1.25. Wacker Chemie AG
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing